Pulmocide Ltd., ("the Company”), a late-stage biopharmaceutical company developing inhaled opelconazole for patients suffering from ser ...

Azole derivatives have been used as antifungal drugs in clinical practice for many years. However, limitations such as ...

Fosravuconazole is under clinical development by Eisai and currently in Phase III for Fungal Infections. According to GlobalData, Phase III drugs for Fungal Infections have a 53% phase transition ...

Chemical modification describes the modification, addition or removal, through chemical reaction, of any of a variety of macromolecules, including proteins and nucleic acids. It refers to the use ...

University of Bremen, Institute for Organic and Analytical Chemistry, Bremen 28359, Germany University of Bremen, Institute for Physical and Theoretical Chemistry, Bremen 28359, Germany University of ...